CollPlant Biotechnologies Ltd
Income Statement
| Line Item | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $179.0K | — | $249.0K | — | $10.2M | — | $66.0K |
| Cost of Revenue | — | $186.0K | — | $536.0K | — | $615.0K | — | $43.0K |
| Gross Profit | — | $-7.0K | — | $-287.0K | — | $9.6M | — | $23.0K |
| Gross Margin | — | -3.9% | — | -115.3% | — | 94.0% | — | 34.8% |
| Operating Expenses | ||||||||
| Research & Development | — | $2.0M | — | $2.7M | — | $2.6M | — | $2.6M |
| SG&A Expense | — | $1.2M | — | $1.4M | — | $1.3M | — | $1.6M |
| Operating Income | — | $-3.2M | — | $-4.4M | — | $5.7M | — | $-4.2M |
| Operating Margin | — | -1,775.4% | — | -1,769.5% | — | 55.7% | — | -6,340.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-3.3M | — | $-4.2M | — | $5.8M | — | $-4.3M |
| Net Margin | — | -1,869.8% | — | -1,690.8% | — | 56.6% | — | -6,492.4% |
| EPS (Basic) | — | $0.28 | — | $0.37 | — | $0.51 | — | $-0.39 |
| EPS (Diluted) | — | $0.28 | — | $0.37 | — | $0.49 | — | $-0.39 |
| Shares Outstanding (Basic) | 12.8M | 11.8M | 11.5M | 11.5M | 11.5M | 11.4M | 11.2M | 11.1M |
| Shares Outstanding (Diluted) | 12.8M | 11.8M | 11.5M | 11.5M | 11.5M | 11.8M | 11.2M | 11.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |